<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>Molecular Evolvability In Theory And In A Bacterial Drug-Resistence Gene</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>03/15/2004</AwardEffectiveDate>
<AwardExpirationDate>02/28/2007</AwardExpirationDate>
<AwardTotalIntnAmount>229999.00</AwardTotalIntnAmount>
<AwardAmount>235999</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>08010207</Code>
<Directorate>
<Abbreviation>BIO</Abbreviation>
<LongName>Direct For Biological Sciences</LongName>
</Directorate>
<Division>
<Abbreviation>DEB</Abbreviation>
<LongName>Division Of Environmental Biology</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Mark Courtney</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>Genetic mutations are random changes in an organism's genome.  They are almost always harmful to the individual, but rare beneficial mutations do occur.  Familiar examples of the latter include mutations for antibiotic resistance in bacteria, vaccine resistance in influenza viruses, and insecticide resistance in insects.  In spite of their great medical and agricultural importance, beneficial mutations are not well understood because they are so rare.  One critical issue is whether two or more beneficial mutations interact to produce greater effects than would be expected from their individual effects.  Drs. Weinreich and Hartl will study this issue in the bacterium Escherichia coli, using a gene for resistance to the widely used antibiotic cefotaxime.  Five different mutations in that gene have been associated with resistance.  To investigate their interactions, the researchers will make all possible combinations of those mutations and study their effects on cefotaxime resistance.&lt;br/&gt;&lt;br/&gt;Broad benefits are likely to flow from the proposed research.  Many infectious diseases are caused by viruses or microorganisms that, in response to clinical use of drug therapy, evolve beneficial mutations so rapidly that even the newest drugs become ineffective before still newer drugs can be developed.  Research on drug resistance will lead to a better understanding of the origin of these "super bugs" and of drug resistance in viruses such as HIV.  The study also addresses several general questions of evolutionary theory.  &lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>02/05/2004</MinAmdLetterDate>
<MaxAmdLetterDate>05/21/2004</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.074</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0343598</AwardID>
<Investigator>
<FirstName>Daniel</FirstName>
<LastName>Hartl</LastName>
<PI_MID_INIT>L</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Daniel L Hartl</PI_FULL_NAME>
<EmailAddress>dhartl@oeb.harvard.edu</EmailAddress>
<PI_PHON>6174963917</PI_PHON>
<NSF_ID>000337167</NSF_ID>
<StartDate>02/05/2004</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Harvard University</Name>
<CityName>Cambridge</CityName>
<CountyName>MIDDLESEX</CountyName>
<ZipCode>021385369</ZipCode>
<PhoneNumber>6174955501</PhoneNumber>
<StreetAddress>1033 MASSACHUSETTS AVE</StreetAddress>
<StreetAddress2><![CDATA[5th Floor]]></StreetAddress2>
<CountryName>United States</CountryName>
<StateName>Massachusetts</StateName>
<StateCode>MA</StateCode>
<CONGRESSDISTRICT>05</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>MA05</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>082359691</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>PRESIDENT AND FELLOWS OF HARVARD COLLEGE</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>001963263</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[Harvard University]]></Name>
<CityName>Cambridge</CityName>
<CountyName>MIDDLESEX</CountyName>
<StateCode>MA</StateCode>
<ZipCode>021385369</ZipCode>
<StreetAddress><![CDATA[1033 MASSACHUSETTS AVE]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Massachusetts</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>05</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>MA05</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0312000</Code>
<Name>Population</Name>
</FoaInformation>
<ProgramElement>
<Code>1112</Code>
<Text>Genetic Mechanisms</Text>
</ProgramElement>
<ProgramElement>
<Code>1127</Code>
<Text>Evolutionary Processes</Text>
</ProgramElement>
<ProgramReference>
<Code>1112</Code>
<Text>GENES AND GENOME SYSTEMS</Text>
</ProgramReference>
<ProgramReference>
<Code>1156</Code>
<Text>MICROBIAL GENETICS</Text>
</ProgramReference>
<ProgramReference>
<Code>1355</Code>
<Text>EGC EDUCATIONAL ACTIVITIES</Text>
</ProgramReference>
<ProgramReference>
<Code>9169</Code>
<Text>BIODIVERSITY AND ECOSYSTEM DYNAMICS</Text>
</ProgramReference>
<ProgramReference>
<Code>9178</Code>
<Text>UNDERGRADUATE EDUCATION</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>EGCH</Code>
<Text>ENVIRONMENT AND GLOBAL CHANGE</Text>
</ProgramReference>
<ProgramReference>
<Code>SMET</Code>
<Text>SCIENCE, MATH, ENG &amp; TECH EDUCATION</Text>
</ProgramReference>
<Appropriation>
<Code>0104</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2004~235999</FUND_OBLG>
</Award>
</rootTag>
